EcoDrugPlus

Integrin Subunit Beta 7

Ensembl ID : ENSSTOG00000011195
Gene Symbol: ITGB7
3 Cross references
160 Possible Orthologues:

Integrin Subunit Beta 8

Ensembl ID : ENSSTOG00000016396
Gene Symbol: ITGB8
3 Cross references
202 Possible Orthologues:

Intercellular Adhesion Molecule 1

Ensembl ID : ENSSTOG00000031629
Gene Symbol: ICAM1
4 Cross references
93 Possible Orthologues:

Interleukin 1 Receptor Associated Kinase 4

Ensembl ID : ENSSTOG00000013841
Gene Symbol: IRAK4
4 Cross references
202 Possible Orthologues:

Interleukin 5

Ensembl ID : ENSSTOG00000009588
Gene Symbol: IL5
3 Cross references
91 Possible Orthologues:

Interleukin-6

Ensembl ID : ENSSTOG00000025879
Gene Symbol: LOC101960206
2 Cross references
156 Possible Orthologues:

Isocitrate Dehydrogenase (Nadp(+)) 1

Ensembl ID : ENSSTOG00000033564
Gene Symbol: IDH1
3 Cross references
233 Possible Orthologues:

Isocitrate Dehydrogenase (Nadp(+)) 2

Ensembl ID : ENSSTOG00000002733
Gene Symbol: IDH2
4 Cross references
261 Possible Orthologues:

Kallikrein B1

Ensembl ID : ENSSTOG00000009756
Gene Symbol: KLKB1
3 Cross references
206 Possible Orthologues:

Kelch Like Ech Associated Protein 1

Ensembl ID : ENSSTOG00000010114
Gene Symbol: KEAP1
3 Cross references
189 Possible Orthologues:

Kinase Insert Domain Receptor

Ensembl ID : ENSSTOG00000016171
Gene Symbol: KDR
3 Cross references
197 Possible Orthologues:

Kinesin Family Member 11

Ensembl ID : ENSSTOG00000006209
Gene Symbol: KIF11
3 Cross references
202 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).